pomalidomide

FDA Drug Profile — pomalidomide, Pomalidomide, Pomalyst

pomalidomide is listed in the FDA National Drug Code directory with 21 NDC codes, marketed under brand names including pomalidomide, Pomalidomide, Pomalyst. Available dosage forms: capsule, powder.

Drug details

Generic Name
pomalidomide
Brand Names
pomalidomide, Pomalidomide, Pomalyst
Application Number
ANDA210245
Sponsor
Novadoz Pharmaceuticals LLC
NDC Codes
21
Dosage Forms
CAPSULE, POWDER
Routes
ORAL
Active Ingredients
POMALIDOMIDE, REGORAFENIB ANHYDROUS

Indications and Usage

1 INDICATIONS AND USAGE Pomalidomide capsules are a thalidomide analogue indicated for the treatment of adult patients: in combination with dexamethasone, for patients with multiple myeloma (MM) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy (1.1). 1.1 Multiple Myeloma Pomalidomide capsules, in combination with dexamethasone, is indicated for adult patients with multiple myeloma (MM) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.